Protein Glycation: An Old Villain is Shedding Secrets

Area of Science:

• Biochemistry
• Pathology
• Medicinal Chemistry

Background:

• Protein glycation involves the non-physiological post-translational addition of carbohydrates to proteins and lipids.
• While known for decades, the pathogenic role of glycated proteins is now widely accepted in various diseases.
• Glycation links metabolic, autoimmune, and neurological disorders, suggesting a common underlying mechanism.

Purpose of the Study:

• To review current knowledge on the causes, structural implications, and pathological consequences of protein glycation.
• To introduce emerging therapeutic strategies for glycation-related pathologies.
• To highlight challenges and opportunities in targeting glycation for medical intervention.

Main Methods:

• Literature review of existing research on protein glycation.
• Analysis of the structural and pathological impacts of glycation.
• Overview of current and emerging therapeutic approaches.

Main Results:

• Glycation contributes to the etiology of diverse diseases including diabetes, arthritis, lupus, multiple sclerosis, ALS, Alzheimer's, and Parkinson's.
• A glycation/inflammation paradigm offers new insights into disease mechanisms.
• Emerging therapeutic strategies target glycation pathways.

Conclusions:

• Protein glycation is a significant toxicological phenomenon with broad pathological implications.
• Targeting glycation presents novel opportunities for drug development and treatment.
• Further research is needed to overcome challenges in addressing glycation pathologies.